Personal information

Keywords

szaok

Activities

Collapse all

Works (14)

Evaluation of the Effectiveness and Safety of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease: An International Real‐Life Retrospective Multicentre Cohort Study

Alimentary Pharmacology & Therapeutics
2025-01 | Journal article
DOI: 10.1111/apt.18359
Contributors: Péter Bacsur; Daniel Shaham; Zuzana Serclova; Tamás Resál; Bernadett Farkas; Patrícia Sarlós; Pál Miheller; Nitsan Maharshak; Meir Zemel; Ariella Bar‐Gil Shitrit et al.
Source: check_circle
Crossref

The effect of the coronavirus disease 2019 pandemic on different areas of gastroenterology

2024-04-04 | Dissertation or Thesis
DOI: 10.14232/phd.12019
Contributors: Tamás Resál
Source: check_circle
Crossref

Plasminogen Activator Inhibitor 1 Is a Novel Faecal Biomarker for Monitoring Disease Activity and Therapeutic Response in Inflammatory Bowel Diseases

Journal of Crohn's and Colitis
2024-03-01 | Journal article
DOI: 10.1093/ecco-jcc/jjad160
Contributors: Boldizsár Jójárt; Tamás Resál; Diána Kata; Tünde Molnár; Péter Bacsur; Viktória Szabó; Árpád Varga; Kata Judit Szántó; Petra Pallagi; Imre Földesi et al.
Source: check_circle
Crossref

Accuracy of the Pancolonic Modified Mayo Score in predicting the long-term outcomes of ulcerative colitis: a promising scoring system

Therapeutic Advances in Gastroenterology
2024-01 | Journal article
DOI: 10.1177/17562848241239606
Contributors: Péter Bacsur; Panu Wetwittayakhlang; Tamás Resál; Emese Földi; Béla Vasas; Bernadett Farkas; Mariann Rutka; Talat Bessissow; Waqqas Afif; Anita Bálint et al.
Source: check_circle
Crossref

Comparison of risk of malignancy and predictive value of diagnostic categories defined by Papanicolaou Society of Cytopathology system and WHO reporting system for pancreaticobiliary cytopathology in solid pancreatic lesions

Therapeutic Advances in Gastroenterology
2024-01 | Journal article
DOI: 10.1177/17562848241271958
Contributors: Béla Vasas; Anna Fábián; Zsófia Bősze; Sándor Hamar; László Kaizer; Tibor Tóth; Péter Bacsur; Tamás Resál; Anita Bálint; Klaudia Farkas et al.
Source: check_circle
Crossref

Outcomes of treatment cessation after switching to subcutaneous vedolizumab treatment in inflammatory bowel diseases

Therapeutic Advances in Gastroenterology
2024-01 | Journal article
DOI: 10.1177/17562848241290636
Contributors: Péter Bacsur; Tamás Resál; Patrícia Sarlós; Ákos Iliás; Liza Dalma Sümegi; Diána Kata; Anett Dávid; Bernadett Farkas; Emese Ivány; Anita Bálint et al.
Source: check_circle
Crossref

Letter: Experience of switching vedolizumab treatment from intravenous to subcutaneous formulation in Hungary

Alimentary Pharmacology & Therapeutics
2023-07 | Journal article
DOI: 10.1111/apt.17610
Contributors: Péter Bacsur; Ákos Iliás; Tamás Resál; Diána Kata; Tamás Molnár; Klaudia Farkas
Source: check_circle
Crossref

Real life efficacy of tofacitinib in various situations in ulcerative colitis: a retrospective worldwide multicenter collaborative study

2023-06-22 | Other
DOI: 10.1093/ibd/izad135
Contributors: Tamás Molnár; Fabiana Castiglione; Henit Yanai; Renáta Bor; Tamás Szamosi; Patrícia Sarlós; Alessandro Armuzzi; Péter Bacsur; Stéphane Nancey; Tamás Resál et al.
Source: check_circle
Crossref

Burnout among European IBD specialists: a survey supported by ECCO

Therapeutic Advances in Gastroenterology
2023-01 | Journal article
DOI: 10.1177/17562848231214086
Contributors: Anett Dávid; Márta Volosin; Klaudia Farkas; Tamás Resál; Csilla Keresztes; Beatrix Rafael; Tamás Molnár
Source: check_circle
Crossref

Nationwide experiences with trough levels, durability, and disease activity among inflammatory bowel disease patients following COVID-19 vaccination

Therapeutic Advances in Gastroenterology
2023-01 | Journal article
DOI: 10.1177/17562848231183529
Contributors: Tamás Resál; Péter Bacsur; Miklós Horváth; Kata Szántó; Mariann Rutka; Anita Bálint; Anna Fábián; Renáta Bor; Zoltán Szepes; János Fekete et al.
Source: check_circle
Crossref

Post-inflammatory polyps burden as a prognostic marker of disease-outcome in patients with inflammatory bowel disease

2022-10-31 | Other
DOI: 10.1093/ecco-jcc/jjac169
Contributors: Pierre Ellul; George Michalopoulos; Liberato Camilleri; Dimitrios Christodoulou; Henit Yanai; Tamás Molnár; Gordon Moran; Frank Phillips; Konstantinos Karmiris; Gerassimos Mantzaris et al.
Source: check_circle
Crossref

Appendiceal Mucinous Neoplasm Appearance on NBI Colonoscopy

Journal of Gastrointestinal and Liver Diseases
2022-09-15 | Journal article
DOI: 10.15403/jgld-4478
Contributors: Péter Bacsur; Tamás Resál; Klaudia Farkas; Szabolcs Ábrahám; Tamás Molnár
Source: check_circle
Crossref

Still the Joker in the Pack: When to Take Out Cyclosporine in the Game?

Inflammatory Bowel Diseases
2021-07-27 | Journal article
DOI: 10.1093/ibd/izab066
Contributors: Tamás Resál; Kata Szántó; Mariann Rutka; Klaudia Farkas; Tamás Molnár
Source: check_circle
Crossref

Letter: ciclosporin and vedolizumab for steroid‐refractory ulcerative colitis

Alimentary Pharmacology & Therapeutics
2020-08 | Journal article
DOI: 10.1111/apt.15896
Contributors: Tamás Resál; Daniella Pigniczki; Kata Szántó; Mariann Rutka; Klaudia Farkas; Tamas Molnar
Source: check_circle
Crossref
How many people are using ORCID?